Format

Send to

Choose Destination
Genet Res (Camb). 2019 Apr 29;101:e6. doi: 10.1017/S0016672319000041.

A severe clinical phenotype of Noonan syndrome with neonatal hypertrophic cardiomyopathy in the second case worldwide with RAF1 S259Y neomutation.

Author information

1
Biomedical Genomics and Oncogenetics Laboratory LR16IPT05,Institut Pasteur de Tunis,Université Tunis El Manar,Tunis,Tunisia.
2
Department of Pediatrics and Metabolic Diseases,La Rabta Hospital,Faculty of Medicine of Tunis,University of Tunis El Manar,Tunis,Tunisia.
3
Department of Congenital and Hereditary Diseases,Charles Nicolle Hospital,Faculty of Medicine of Tunis,University of Tunis El Manar,Tunis,Tunisia.
4
Aix Marseille Univ,INSERM,MMG,U1251,Marseille Medical Genetics,Marseille,France.
5
Neonatal Resuscitation and Intensive Care Unit of Military Hospital of Tunis,Military Hospital of Tunis,Tunisia.
6
Venoms and Therapeutic Biomolecules Laboratory LR16IPT08,Institut Pasteur de Tunis,Université Tunis El Manar,Tunisia.

Abstract

Noonan syndrome and related disorders are a group of clinically and genetically heterogeneous conditions caused by mutations in genes of the RAS/MAPK pathway. Noonan syndrome causes multiple congenital anomalies, which are frequently accompanied by hypertrophic cardiomyopathy (HCM). We report here a Tunisian patient with a severe phenotype of Noonan syndrome including neonatal HCM, facial dysmorphism, severe failure to thrive, cutaneous abnormalities, pectus excavatum and severe stunted growth, who died in her eighth month of life. Using whole exome sequencing, we identified a de novo mutation in exon 7 of the RAF1 gene: c.776C > A (p.Ser259Tyr). This mutation affects a highly conserved serine residue, a main mediator of Raf-1 inhibition via phosphorylation. To our knowledge the c.776C > A mutation has been previously reported in only one case with prenatally diagnosed Noonan syndrome. Our study further supports the striking correlation of RAF1 mutations with HCM and highlights the clinical severity of Noonan syndrome associated with a RAF1 p.Ser259Tyr mutation.

KEYWORDS:

Noonan syndrome; RAF1 mutation; RAS/MAPK pathway; hypertrophic cardiomyopathy; whole exome sequencing

PMID:
31030682
DOI:
10.1017/S0016672319000041

Supplemental Content

Full text links

Icon for Cambridge University Press
Loading ...
Support Center